Biobeat Technologies , Ltd. FDA Approvals

0 new drug approvals and 3 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product	What it is	Route	Decided
BB-613-BPM510(k)Jan 14, 2025Cardiovascular	Cardiovascular	510(k)Substantially Equivalent (Traditional)	Jan 14, 2025
Biobeat Platform-2 and BB-613WP Patch510(k)Dec 30, 2022Cardiovascular	Cardiovascular	510(k)Substantially Equivalent (Traditional)	Dec 30, 2022
Biobeat Platform, BB-613WP Patch510(k)Mar 25, 2022Cardiovascular	Cardiovascular	510(k)Substantially Equivalent (Traditional)	Mar 25, 2022